BioCentury
ARTICLE | Company News

NantWorks, Sorrento deal

July 13, 2015 7:00 AM UTC

Sorrento and NantWorks formed a JV to develop small molecules to treat cancer. The companies will jointly provide $100 million; NantWorks will own 60% of the JV, and Sorrento will own the remainder. T...